To assess whether assignment of docetaxel dose based on the ERMBT will result in decreased variability in drug area under the curve when compared to dosing based on body surface area. 12 months [clinicaltrials_resource:c34fa541d317841b372f5c2a66d5fa3a]
You will then receive your first dose of docetaxel chemotherapy. It is put through your IV over 1-2 hours. you will receive docetaxel every 3 weeks in the Cancer Center Infusion area.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
To assess whether assignment of docetaxel dose based on the ERMBT will result in decreased variability in drug area under the curve when compared to dosing based on body surface area. 12 months [clinicaltrials_resource:c34fa541d317841b372f5c2a66d5fa3a]
You will then receive your first dose of docetaxel chemotherapy. It is put through your IV over 1-2 hours. you will receive docetaxel every 3 weeks in the Cancer Center Infusion area.
Bio2RDF identifier
c34fa541d317841b372f5c2a66d5fa3a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c34fa541d317841b372f5c2a66d5fa3a
measure [clinicaltrials_vocabulary:measure]
To assess whether assignment o ...... ng based on body surface area.
time frame [clinicaltrials_vocabulary:time-frame]
description
You will then receive your fir ...... e Cancer Center Infusion area.
identifier
clinicaltrials_resource:c34fa541d317841b372f5c2a66d5fa3a
title
To assess whether assignment o ...... n body surface area. 12 months
@en
type
label
To assess whether assignment o ...... fa541d317841b372f5c2a66d5fa3a]
@en